PI3K/AKT inhibition effectively attenuates MMP-9 expression induced by tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and reduces ECM deposition, thereby delaying the development of liver fibrosis [35]. Here, AKT1 is linked to Hepatic fibrosis.